{"transactions":[{"id":4638253,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T23:21:16.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":2624,"price":37,"value":97088.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 6, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 36,459 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 6, 2027 (subject to continuous employment with the Issuer and/or its affiliates)."}],"balance_after":463033,"source":{"system":"sec-edgar","filing":"0001104659-26-114777","document":"tm2627257-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1664499/000110465926114777/tm2627257-1_4seq1.xml","form_type":"4"}},{"id":812875,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-08T20:43:38.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 41,667 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates)."}],"balance_after":465657,"source":{"system":"sec-edgar","filing":"0001104659-26-040955","document":"tm2611344-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465926040955/tm2611344-3_4seq1.xml","form_type":"4"}},{"id":854480,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:16:36.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":9266,"price":25.07,"value":232298.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals."}],"balance_after":423990,"source":{"system":"sec-edgar","filing":"0001104659-26-025236","document":"tm268271-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465926025236/tm268271-3_4seq1.xml","form_type":"4"}},{"id":975085,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-10T21:15:34.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":false,"shares":29502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.78,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":29502},"source":{"system":"sec-edgar","filing":"0001104659-25-119985","document":"tm2533040-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925119985/tm2533040-1_4seq1.xml","form_type":"4"}},{"id":975084,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:15:34.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":25866,"price":22,"value":569052.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals."}],"balance_after":433256,"source":{"system":"sec-edgar","filing":"0001104659-25-119985","document":"tm2533040-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925119985/tm2533040-1_4seq1.xml","form_type":"4"}},{"id":975083,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:15:34.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":true,"shares":29502,"price":17.78,"value":524545.56,"ownership":{"direct":true},"balance_after":459122,"source":{"system":"sec-edgar","filing":"0001104659-25-119985","document":"tm2533040-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925119985/tm2533040-1_4seq1.xml","form_type":"4"}},{"id":1218193,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-08T01:04:08.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":9235,"price":27.19,"value":251099.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals."}],"balance_after":429620,"source":{"system":"sec-edgar","filing":"0001104659-25-021864","document":"tm258649-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925021864/tm258649-2_4seq1.xml","form_type":"4"}},{"id":1264794,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T02:50:11.000Z","date":"2025-02-15","kind":"other","planned":false,"acquired":true,"shares":26232,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares of the Issuer's common stock pursuant to the pro rata distribution for no consideration by APC, of which the Reporting Person is a stockholder."}],"balance_after":1133706,"source":{"system":"sec-edgar","filing":"0001104659-25-014912","document":"tm253769-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925014912/tm253769-1_4seq1.xml","form_type":"4"}},{"id":1264793,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T02:50:11.000Z","date":"2025-02-15","kind":"other","planned":false,"acquired":false,"shares":699896,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Allied Physicians of California, a Professional Medical Corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"APC distributed these shares of the Issuer's common stock to its stockholders, pursuant to a pro rata distribution for no consideration. Includes 17,839 shares in the aggregate held for the benefit of disqualified shareholders of APC."},{"field":"shares","element":"transactionShares","label":"F2","text":"APC distributed these shares of the Issuer's common stock to its stockholders, pursuant to a pro rata distribution for no consideration. Includes 17,839 shares in the aggregate held for the benefit of disqualified shareholders of APC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation (\"APC\"), of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":6132802,"source":{"system":"sec-edgar","filing":"0001104659-25-014912","document":"tm253769-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925014912/tm253769-1_4seq1.xml","form_type":"4"}},{"id":1298151,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":83136,"kind":"organization","name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","position":1,"cik":"0001725602","reported_name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53297,"kind":"person","name":"Lam Thomas S.","position":2,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":53296,"kind":"person","name":"Sim Kenneth T.","position":3,"cik":"0001725499","reported_name":"Sim Kenneth T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2025-01-23T00:46:11.000Z","date":"2025-01-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"price":35.17,"value":10551000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 17, 2025, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase 300,000 shares of the issuer's common stock from APC. The agreement closed, and the issuer completed the stock repurchase, on the same day. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Allied Physicians of California, a Professional Medical Corporation (\"APC\"), is a consolidated affiliate of the issuer of which Dr. Kenneth Sim, the issuer's Executive Chairman of the Board of Directors, is Chairman and a director and stockholder, and Dr. Thomas Lam, the issuer's Vice Chairman of the Board of Directors, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. Each of Dr. Sim and Dr. Lam disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Sim and Dr. Lam holds, directly and/or indirectly, additional securities of the issuer."}],"balance_after":6832698,"source":{"system":"sec-edgar","filing":"0001104659-25-005342","document":"tm253769-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925005342/tm253769-4_4seq1.xml","form_type":"4"}},{"id":1369643,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-12T21:36:08.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":26667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 50%, 25% and 25%, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 130,000 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 43,333 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; and (ii) grants of 30,000 shares, 30,000 shares and 26,667 shares, each of which will vest upon achievement of certain pre-established performance goals."}],"balance_after":438855,"source":{"system":"sec-edgar","filing":"0001104659-24-116856","document":"tm2428142-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924116856/tm2428142-5_4seq1.xml","form_type":"4"}},{"id":1369642,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-12T21:36:08.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors."}],"balance_after":412188,"source":{"system":"sec-edgar","filing":"0001104659-24-116856","document":"tm2428142-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924116856/tm2428142-5_4seq1.xml","form_type":"4"}},{"id":1410157,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T21:39:16.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":false,"shares":28046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.65,"expiration_date":"2024-12-30","underlying":"Common Stock","underlying_shares":28046},"source":{"system":"sec-edgar","filing":"0001104659-24-098982","document":"tm2423811-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924098982/tm2423811-3_4seq1.xml","form_type":"4"}},{"id":1410156,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T21:39:16.000Z","date":"2024-09-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":11046,"price":47.35,"value":523028.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals."}],"balance_after":398855,"source":{"system":"sec-edgar","filing":"0001104659-24-098982","document":"tm2423811-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924098982/tm2423811-3_4seq1.xml","form_type":"4"}},{"id":1410155,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T21:39:16.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":true,"shares":28046,"price":18.65,"value":523057.9,"ownership":{"direct":true},"balance_after":409901,"source":{"system":"sec-edgar","filing":"0001104659-24-098982","document":"tm2423811-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924098982/tm2423811-3_4seq1.xml","form_type":"4"}},{"id":1707942,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2023-12-18T21:35:47.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 15,000, 7,500 and 7,500, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals."}],"balance_after":381855,"source":{"system":"sec-edgar","filing":"0001104659-23-126900","document":"tm2333076-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923126900/tm2333076-5_4seq1.xml","form_type":"4"}},{"id":1707941,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2023-12-18T21:35:47.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall vest in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors."}],"balance_after":351855,"source":{"system":"sec-edgar","filing":"0001104659-23-126900","document":"tm2333076-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923126900/tm2333076-5_4seq1.xml","form_type":"4"}},{"id":1707940,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2023-12-18T21:35:47.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors."}],"balance_after":321855,"source":{"system":"sec-edgar","filing":"0001104659-23-126900","document":"tm2333076-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923126900/tm2333076-5_4seq1.xml","form_type":"4"}},{"id":1739603,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":83136,"kind":"organization","name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","position":1,"cik":"0001725602","reported_name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53297,"kind":"person","name":"Lam Thomas S.","position":2,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO and President"}},{"id":53296,"kind":"person","name":"Sim Kenneth T.","position":3,"cik":"0001725499","reported_name":"Sim Kenneth T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":108221,"kind":"person","name":"Young Albert WaiChow","position":4,"cik":"0001725420","reported_name":"Young Albert WaiChow","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2023-11-16T21:31:17.000Z","date":"2023-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3166561,"price":31.58,"value":99999996.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 6, 2023, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase approximately $100 million of the issuer's common stock from APC. Pursuant to such agreement, on November 14, 2023, the issuer repurchased 3,166,561 shares of common stock from APC. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Allied Physicians of California, a Professional Medical Corporation (\"APC\") is a consolidated affiliate of the issuer of which Dr. Thomas Lam, the issuer's Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the issuer's Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the issuer's Chief Administrative Officer, is Senior Executive Vice President and a director and stockholder. Each of Dr. Lam, Dr. Sim and Dr. Young disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Lam, Dr. Sim and Dr. Young holds, directly and/or indirectly, additional securities of the issuer."}],"balance_after":7132698,"source":{"system":"sec-edgar","filing":"0001104659-23-119144","document":"tm2330683-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923119144/tm2330683-1_4seq1.xml","form_type":"4"}},{"id":2091407,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":83136,"kind":"organization","name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","position":1,"cik":"0001725602","reported_name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53297,"kind":"person","name":"Lam Thomas S.","position":2,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}},{"id":53296,"kind":"person","name":"Sim Kenneth T.","position":3,"cik":"0001725499","reported_name":"Sim Kenneth T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":108221,"kind":"person","name":"Young Albert WaiChow","position":4,"cik":"0001725420","reported_name":"Young Albert WaiChow","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2022-12-09T23:43:49.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":52262.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger).  Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":52262.84},"source":{"system":"sec-edgar","filing":"0001250853-22-000120","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000120/primary_doc.xml","form_type":"4"}},{"id":2091406,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":83136,"kind":"organization","name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","position":1,"cik":"0001725602","reported_name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53297,"kind":"person","name":"Lam Thomas S.","position":2,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}},{"id":53296,"kind":"person","name":"Sim Kenneth T.","position":3,"cik":"0001725499","reported_name":"Sim Kenneth T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":108221,"kind":"person","name":"Young Albert WaiChow","position":4,"cik":"0001725420","reported_name":"Young Albert WaiChow","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2022-12-09T23:43:49.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":55337.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger).  Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":55337.13},"source":{"system":"sec-edgar","filing":"0001250853-22-000120","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000120/primary_doc.xml","form_type":"4"}},{"id":2091405,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":83136,"kind":"organization","name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","position":1,"cik":"0001725602","reported_name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53297,"kind":"person","name":"Lam Thomas S.","position":2,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}},{"id":53296,"kind":"person","name":"Sim Kenneth T.","position":3,"cik":"0001725499","reported_name":"Sim Kenneth T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":108221,"kind":"person","name":"Young Albert WaiChow","position":4,"cik":"0001725420","reported_name":"Young Albert WaiChow","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2022-12-09T23:43:49.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":52262,"price":11,"value":574882.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person."}],"balance_after":10299259,"source":{"system":"sec-edgar","filing":"0001250853-22-000120","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000120/primary_doc.xml","form_type":"4"}},{"id":2091404,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":83136,"kind":"organization","name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp","position":1,"cik":"0001725602","reported_name":"ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53297,"kind":"person","name":"Lam Thomas S.","position":2,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}},{"id":53296,"kind":"person","name":"Sim Kenneth T.","position":3,"cik":"0001725499","reported_name":"Sim Kenneth T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}},{"id":108221,"kind":"person","name":"Young Albert WaiChow","position":4,"cik":"0001725420","reported_name":"Young Albert WaiChow","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2022-12-09T23:43:49.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":55337,"price":10,"value":553370.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person."}],"balance_after":10246997,"source":{"system":"sec-edgar","filing":"0001250853-22-000120","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000120/primary_doc.xml","form_type":"4"}},{"id":2093773,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Warrants to purchase Common Stock","published_at":"2022-12-08T00:04:34.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":48585.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger).  Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer)."}],"balance_after":0,"derivative":{"exercise_price":11,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":48585.84},"source":{"system":"sec-edgar","filing":"0001250853-22-000118","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000118/primary_doc.xml","form_type":"4"}},{"id":2093772,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Warrants to purchase Common Stock","published_at":"2022-12-08T00:04:34.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":51442.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger).  Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer)."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":51442.83},"source":{"system":"sec-edgar","filing":"0001250853-22-000118","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000118/primary_doc.xml","form_type":"4"}},{"id":2093771,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-08T00:04:34.000Z","date":"2022-12-05","kind":"exercise","acquired":true,"shares":48585,"price":11,"value":534435.0,"ownership":{"direct":true},"balance_after":291855,"source":{"system":"sec-edgar","filing":"0001250853-22-000118","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000118/primary_doc.xml","form_type":"4"}},{"id":2093770,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-08T00:04:34.000Z","date":"2022-12-05","kind":"exercise","acquired":true,"shares":51443,"price":10,"value":514430.0,"ownership":{"direct":true},"balance_after":243270,"source":{"system":"sec-edgar","filing":"0001250853-22-000118","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000118/primary_doc.xml","form_type":"4"}},{"id":2094873,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-07T02:36:10.000Z","date":"2022-12-02","kind":"other","acquired":true,"shares":37439,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied, of which the Reporting Person is a director, officer and shareholder."}],"balance_after":1107474,"source":{"system":"sec-edgar","filing":"0001250853-22-000115","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000115/primary_doc.xml","form_type":"4"}},{"id":2094872,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-07T02:36:10.000Z","date":"2022-12-02","kind":"other","acquired":false,"shares":984042,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Allied Physicians of California, A Professional Medical Corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Allied Physicians of California, A Profession Medical Corporation (\"Allied\"), of which the Reporting Person is a director, officer and shareholder, distributed these shares as an in-kind dividend to its shareholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are beneficially owned by Allied, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":10191660,"source":{"system":"sec-edgar","filing":"0001250853-22-000115","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000115/primary_doc.xml","form_type":"4"}},{"id":2098880,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-02T23:30:17.000Z","date":"2022-09-27","kind":"gift","acquired":false,"shares":383764,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By wife"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On September 17, 2020, the spouse of the Reporting Person contributed 564, 691 shares of AMEH common stock to a grantor retained annuity trust (the JL GRAT) for the benefit of herself and her children.  On September 27, 2021 45,836 shares were distributed from the JL GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 135,090 shares were distributed from the JL GRAT to the Family Trust in satisfaction of an annuity obligation.  Upon termination of the trust on September 27, 2022, the remaining 383,764 shares were transferred to the children of the Reporting Person.  The 180,926 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-22-000096","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000096/primary_doc.xml","form_type":"4"}},{"id":2098879,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-02T23:30:17.000Z","date":"2022-09-27","kind":"gift","acquired":false,"shares":383764,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 17, 2020, the Reporting Person contributed 564,691 shares of AMEH common stock to a grantor retained annuity trust (the TL GRAT) for the benefit of himself and his children.  On September 27, 2021 45,836 shares were distributed from the TL GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 135,090 shares were distributed from the TL GRAT to the Family Trust in satisfaction of an annuity obligation.  Upon termination of the trust on September 27, 2022, the remaining 383,764 shares were transferred to the children of the Reporting Person.  The 180,926 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001250853-22-000096","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000096/primary_doc.xml","form_type":"4"}},{"id":2098878,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2022-12-02T23:30:17.000Z","date":"2022-03-03","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002 (the Family Trust). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":799855,"source":{"system":"sec-edgar","filing":"0001250853-22-000096","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000096/primary_doc.xml","form_type":"4"}},{"id":2525048,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-05T00:25:54.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":29502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the option shall vest in three equal annual installments commencing on the first anniversary of November 2, 2021."}],"balance_after":29502,"derivative":{"exercise_price":71.45,"expiration_date":"2026-11-02","underlying":"Common Stock","underlying_shares":29502},"source":{"system":"sec-edgar","filing":"0001628280-21-021872","document":"wf-form4_163607193862764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828021021872/wf-form4_163607193862764.xml","form_type":"4"}},{"id":2525047,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2021-11-05T00:25:54.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":65242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191827,"source":{"system":"sec-edgar","filing":"0001628280-21-021872","document":"wf-form4_163607193862764.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828021021872/wf-form4_163607193862764.xml","form_type":"4"}},{"id":2725419,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2021-05-06T23:12:55.000Z","date":"2021-03-30","kind":"exercise","acquired":true,"shares":31755,"price":10,"value":317550.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":908183,"source":{"system":"sec-edgar","filing":"0001104659-21-062587","document":"tm2115461-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465921062587/tm2115461-1_4seq1.xml","form_type":"4/A","original_submission_date":"2021-04-01"}},{"id":2725418,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2021-05-06T23:12:55.000Z","date":"2020-12-22","kind":"other","acquired":true,"shares":185938,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied Physicians of California, A Profession Medical Corporation (\"Allied\") of which the Reporting Person is a director, officer and shareholder."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied Physicians of California, A Profession Medical Corporation (\"Allied\") of which the Reporting Person is a director, officer and shareholder."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied Physicians of California, A Profession Medical Corporation (\"Allied\") of which the Reporting Person is a director, officer and shareholder."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":876428,"source":{"system":"sec-edgar","filing":"0001104659-21-062587","document":"tm2115461-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465921062587/tm2115461-1_4seq1.xml","form_type":"4/A","original_submission_date":"2021-04-01"}},{"id":2764977,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-04-02T00:46:15.000Z","date":"2021-03-30","kind":"exercise","acquired":false,"shares":31755,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2017-12-07","expiration_date":"2021-03-30","underlying":"Common Stock","underlying_shares":31755},"source":{"system":"sec-edgar","filing":"0001250853-21-000044","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085321000044/primary_doc.xml","form_type":"4"}},{"id":2764976,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2021-04-02T00:46:15.000Z","date":"2021-03-30","kind":"exercise","acquired":true,"shares":31755,"price":10,"value":317550.0,"ownership":{"direct":false,"nature":"By the Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":908183,"source":{"system":"sec-edgar","filing":"0001250853-21-000044","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085321000044/primary_doc.xml","form_type":"4"}},{"id":2949012,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-12T02:30:43.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":29502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in three equal annual installments commencing on November 11, 2020."}],"balance_after":29502,"derivative":{"exercise_price":17.78,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":29502},"source":{"system":"sec-edgar","filing":"0001250853-20-000110","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000110/primary_doc.xml","form_type":"4"}},{"id":2949011,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-12-12T02:30:43.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":65242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":126585,"source":{"system":"sec-edgar","filing":"0001250853-20-000110","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000110/primary_doc.xml","form_type":"4"}},{"id":3031666,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-09-16T01:54:05.000Z","date":"2020-09-14","kind":"purchase","acquired":true,"shares":5000,"price":17.2762,"value":86381.0,"ownership":{"direct":false,"nature":"By Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $17.225  to $17.33, inclusive. The reporting person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":690490,"source":{"system":"sec-edgar","filing":"0001250853-20-000079","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000079/primary_doc.xml","form_type":"4"}},{"id":3033506,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-09-12T00:28:54.000Z","date":"2020-09-10","kind":"other","acquired":true,"shares":564691,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By wife"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 10, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are beneficially owned by the Reporting Person's spouse as separate property pursuant to the transmutation agreement referred to in footnote one. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":564691,"source":{"system":"sec-edgar","filing":"0001250853-20-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000072/primary_doc.xml","form_type":"4"}},{"id":3033505,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-09-12T00:28:54.000Z","date":"2020-09-10","kind":"other","acquired":false,"shares":564691,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 10, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":685490,"source":{"system":"sec-edgar","filing":"0001250853-20-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000072/primary_doc.xml","form_type":"4"}},{"id":3034625,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Warrants to Purchase Common Stock","published_at":"2020-09-11T01:25:07.000Z","date":"2020-09-08","kind":"exercise","acquired":false,"shares":63510,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2017-12-07","expiration_date":"2020-10-14","underlying":"Common Stock","underlying_shares":63510},"source":{"system":"sec-edgar","filing":"0001250853-20-000068","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000068/primary_doc.xml","form_type":"4"}},{"id":3034624,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-09-11T01:25:07.000Z","date":"2020-09-09","kind":"purchase","acquired":true,"shares":5000,"price":17.85,"value":89250.0,"ownership":{"direct":false,"nature":"By Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1814872,"source":{"system":"sec-edgar","filing":"0001250853-20-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000068/primary_doc.xml","form_type":"4"}},{"id":3034623,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-09-11T01:25:07.000Z","date":"2020-09-08","kind":"tax_withholding","acquired":false,"shares":30252,"price":18.89,"value":571460.28,"ownership":{"direct":false,"nature":"By Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1809872,"source":{"system":"sec-edgar","filing":"0001250853-20-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000068/primary_doc.xml","form_type":"4"}},{"id":3034622,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-09-11T01:25:07.000Z","date":"2020-09-08","kind":"exercise","acquired":true,"shares":63510,"price":9,"value":571590.0,"ownership":{"direct":false,"nature":"By Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1840124,"source":{"system":"sec-edgar","filing":"0001250853-20-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000068/primary_doc.xml","form_type":"4"}},{"id":3043959,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2020-08-31T22:46:58.000Z","date":"2020-08-27","kind":"purchase","acquired":true,"shares":5000,"price":18.23,"value":91150.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.20 to $18.30. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1776614,"source":{"system":"sec-edgar","filing":"0001104659-20-100935","document":"tm2029851d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465920100935/tm2029851d1_4.xml","form_type":"4"}},{"id":3329887,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-31T02:49:12.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":28046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company."}],"balance_after":28046,"derivative":{"exercise_price":18.65,"expiration_date":"2024-12-30","underlying":"Common Stock","underlying_shares":28046},"source":{"system":"sec-edgar","filing":"0001104659-19-076941","document":"tm1928380d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919076941/tm1928380d3_4.xml","form_type":"4"}},{"id":3329886,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2019-12-31T02:49:12.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":61343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the \"Company\") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022)."}],"balance_after":61343,"source":{"system":"sec-edgar","filing":"0001104659-19-076941","document":"tm1928380d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919076941/tm1928380d3_4.xml","form_type":"4"}},{"id":3329885,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-31T02:26:18.000Z","date":"2019-12-27","kind":"other","acquired":false,"shares":39189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":17.62,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":39189},"source":{"system":"sec-edgar","filing":"0001104659-19-076928","document":"tm1928380d1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919076928/tm1928380d1_4a.xml","form_type":"4/A","original_submission_date":"2019-10-02"}},{"id":3329884,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2019-12-31T02:26:18.000Z","date":"2019-12-27","kind":"other","acquired":false,"shares":58883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\") under the Company's 2015 Equity Incentive Plan."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\") under the Company's 2015 Equity Incentive Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-076928","document":"tm1928380d1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919076928/tm1928380d1_4a.xml","form_type":"4/A","original_submission_date":"2019-10-02"}},{"id":3344039,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2019-12-12T11:03:48.000Z","date":"2019-12-08","kind":"grant","acquired":true,"shares":93450,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Allied Physicians of California, A Professional Medical Corporation"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"date","element":"transactionDate","label":"F2","text":"No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"kind","element":"transactionCoding","label":"F2","text":"No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"shares","element":"transactionShares","label":"F2","text":"No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities acquired represent the Holdback Shares that were released as part of the Merger to Allied Physicians of California, A Professional Medical Corporation of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":17158389,"source":{"system":"sec-edgar","filing":"0001104659-19-071984","document":"tm1925087d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919071984/tm1925087d1_4.xml","form_type":"4"}},{"id":3344038,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2019-12-12T11:03:48.000Z","date":"2019-12-08","kind":"grant","acquired":true,"shares":86874,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"date","element":"transactionDate","label":"F2","text":"No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"kind","element":"transactionCoding","label":"F2","text":"No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"shares","element":"transactionShares","label":"F2","text":"No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes the Reporting Person's indirect ownership of common stock of the Issuer as a shareholder of Allied Physicians of California, A Professional Medical Corporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities acquired are Holdback Shares owned directly by The Thomas and Jeanette Lam 2002 Family Trust.  The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose."}],"balance_after":1830497,"source":{"system":"sec-edgar","filing":"0001104659-19-071984","document":"tm1925087d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919071984/tm1925087d1_4.xml","form_type":"4"}},{"id":3370310,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Co-CEO"}}],"security":"Common Stock","published_at":"2019-11-16T02:22:43.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":10000,"price":14.84,"value":148400.0,"ownership":{"direct":false,"nature":"Held by The Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $14.70 to $14.92.  The price reported above reflects the weighted average purchase price.  The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes the Reporting Person's indirect ownership of common stock of Apollo Medical Holdings, Inc. as a shareholder of Allied Physicians of California, A Professional Medical Corporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust.  The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose."}],"balance_after":1743623,"source":{"system":"sec-edgar","filing":"0001104659-19-064844","document":"tm1923122-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919064844/tm1923122-1_4.xml","form_type":"4"}},{"id":3401627,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-10-02T18:28:12.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":39189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019)."}],"balance_after":39189,"derivative":{"exercise_price":17.62,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":39189},"source":{"system":"sec-edgar","filing":"0001144204-19-046903","document":"tv530495_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000114420419046903/tv530495_4.xml","form_type":"4"}},{"id":3401626,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-10-02T18:28:12.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":58883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted shares of Apollo Medical Holdings, Inc.'s (the \"Company\") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022)."}],"balance_after":58883,"source":{"system":"sec-edgar","filing":"0001144204-19-046903","document":"tv530495_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000114420419046903/tv530495_4.xml","form_type":"4"}},{"id":3415222,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-13T18:34:13.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":15015015,"price":300000000,"value":4.5045045e+15,"ownership":{"direct":false,"nature":"By Allied Physicians of California, A Professional Medical Corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 11, 2019, Apollo Holdings, Medical Inc. (\"AMEH\"), AP-AMH Medical Corporation (\"AP-AMH\"), Allied Physicians of California, a Professional Medical Corporation (\"APC\") and Network Medical Management, Inc. concurrently closed a series of inter-connected transactions, as more fully described in the Form 8-K filed by AMEH with the Securities and Exchange Commission on September 12, 2019. The closing included AMEH issuing to APC a total of 15,015,015 shares of its authorized and unissued common stock for aggregate purchase consideration of $300,000,000, the per share price of $19.98 having been determined at the time of execution of the Stock Purchase Agreement on May 10, 2019. The transaction was exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Rule 506(b) of Regulation D promulgated thereunder, applicable to transactions by an issuer not involving any public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by APC of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":16790575,"source":{"system":"sec-edgar","filing":"0001553350-19-000943","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000943/lam4.xml","form_type":"4"}},{"id":3433467,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-20T23:48:13.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":6000,"price":16.19,"value":97140.0,"ownership":{"direct":false,"nature":"Held by The Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $16.09 to $16.21. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose."}],"balance_after":1674740,"source":{"system":"sec-edgar","filing":"0001553350-19-000874","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000874/lam4.xml","form_type":"4"}},{"id":3433466,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-20T23:48:13.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":4000,"price":15.57,"value":62280.0,"ownership":{"direct":false,"nature":"Held by The Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $15.55 to $15.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose."}],"balance_after":1668740,"source":{"system":"sec-edgar","filing":"0001553350-19-000874","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000874/lam4.xml","form_type":"4"}},{"id":3433465,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-20T23:48:13.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":7200,"price":16.85,"value":121320.0,"ownership":{"direct":false,"nature":"Held by The Thomas and Jeanette Lam 2002 Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $16.63 to $16.92. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose."}],"balance_after":1664740,"source":{"system":"sec-edgar","filing":"0001553350-19-000874","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000874/lam4.xml","form_type":"4"}},{"id":3491729,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-13T23:12:50.000Z","date":"2019-06-11","kind":"purchase","acquired":true,"shares":6900,"price":14.64,"value":101016.0,"ownership":{"direct":true},"balance_after":1657540,"source":{"system":"sec-edgar","filing":"0001553350-19-000638","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000638/lam4.xml","form_type":"4"}},{"id":3578899,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-26T21:28:23.000Z","date":"2018-12-08","kind":"grant","acquired":true,"shares":93451,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Allied Physicians of California, A Professional Medical Corporation"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to former NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"date","element":"transactionDate","label":"F2","text":"No indemnification claim was made before December 8, 2018 and, accordingly, the first half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2018. The book entry issuance of the Reporting Person's pro rata portion of the Holdback Shares was completed on March 22, 2019."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to former NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"kind","element":"transactionCoding","label":"F2","text":"No indemnification claim was made before December 8, 2018 and, accordingly, the first half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2018. The book entry issuance of the Reporting Person's pro rata portion of the Holdback Shares was completed on March 22, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to former NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"shares","element":"transactionShares","label":"F2","text":"No indemnification claim was made before December 8, 2018 and, accordingly, the first half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2018. The book entry issuance of the Reporting Person's pro rata portion of the Holdback Shares was completed on March 22, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares represent the Holdback Shares that were released as part of the Merger to Allied Physicians of California, A Professional Medical Corporation of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":1775560,"source":{"system":"sec-edgar","filing":"0001553350-19-000255","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000255/lam4.xml","form_type":"4"}},{"id":3578898,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-26T21:28:23.000Z","date":"2018-12-08","kind":"grant","acquired":true,"shares":86876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to former NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"date","element":"transactionDate","label":"F2","text":"No indemnification claim was made before December 8, 2018 and, accordingly, the first half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2018. The book entry issuance of the Reporting Person's pro rata portion of the Holdback Shares was completed on March 22, 2019."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to former NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"kind","element":"transactionCoding","label":"F2","text":"No indemnification claim was made before December 8, 2018 and, accordingly, the first half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2018. The book entry issuance of the Reporting Person's pro rata portion of the Holdback Shares was completed on March 22, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the \"Issuer\") and Network Medical Management, Inc. (\"NMM\") was consummated (the \"Merger\"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the \"Holdback Shares\"), which Holdback Shares were to be released to former NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates."},{"field":"shares","element":"transactionShares","label":"F2","text":"No indemnification claim was made before December 8, 2018 and, accordingly, the first half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2018. The book entry issuance of the Reporting Person's pro rata portion of the Holdback Shares was completed on March 22, 2019."}],"balance_after":1650640,"source":{"system":"sec-edgar","filing":"0001553350-19-000255","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000255/lam4.xml","form_type":"4"}},{"id":3980123,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-30T01:42:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":1682109,"ownership":{"direct":false,"nature":"By Allied Physicians of California, A Professional Medical Corporation (\"Allied\")"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."},{"field":"security","element":"securityTitle","label":"F4","text":"Immediately prior to the Closing, Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,682,109 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share (this was previously reported on the Form 4/A filed by the Reporting Person on December 18, 2017), (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share (this was previously reported on the Form 4/A filed by the Reporting Person on December 18, 2017), (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 186,901.07 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Immediately prior to the Closing, Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,682,109 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share (this was previously reported on the Form 4/A filed by the Reporting Person on December 18, 2017), (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share (this was previously reported on the Form 4/A filed by the Reporting Person on December 18, 2017), (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 186,901.07 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Closing, Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,682,109 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share (this was previously reported on the Form 4/A filed by the Reporting Person on December 18, 2017), (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share (this was previously reported on the Form 4/A filed by the Reporting Person on December 18, 2017), (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 186,901.07 shares of common stock of the Issuer)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":1682109,"source":{"system":"sec-edgar","filing":"0001553350-18-000259","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335018000259/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":3980122,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-30T01:42:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":1563763,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Pursuant to and effective as of the closing of the Merger (the \"Closing\"), the Reporting Person became an officer (i.e., Executive Chairman) and director of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"Immediately prior to the Closing, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share (this was previously reported on the Form 4 filed by the Reporting Person on December 12, 2017), (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share (this was previously reported on the Form 4 filed by the Reporting Person on December 12, 2017), (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the Closing, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share (this was previously reported on the Form 4 filed by the Reporting Person on December 12, 2017), (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share (this was previously reported on the Form 4 filed by the Reporting Person on December 12, 2017), (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the Closing, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share (this was previously reported on the Form 4 filed by the Reporting Person on December 12, 2017), (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share (this was previously reported on the Form 4 filed by the Reporting Person on December 12, 2017), (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer)."}],"balance_after":1563763,"source":{"system":"sec-edgar","filing":"0001553350-18-000259","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335018000259/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4128983,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-19T00:37:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":52262.84,"ownership":{"direct":false,"nature":"By Allied"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":52262.84,"derivative":{"exercise_price":11,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":52262.84},"source":{"system":"sec-edgar","filing":"0001553350-17-001403","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001403/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4128982,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-19T00:37:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":55337.13,"ownership":{"direct":false,"nature":"By Allied"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":55337.13,"derivative":{"exercise_price":10,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":55337.13},"source":{"system":"sec-edgar","filing":"0001553350-17-001403","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001403/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4128981,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-19T00:37:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":34158.69,"ownership":{"direct":false,"nature":"By Allied"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."},{"field":"security","element":"securityTitle","label":"F3","text":"Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including Allied) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which Allied will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which Allied will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including Allied) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which Allied will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which Allied will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including Allied) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which Allied will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which Allied will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":34158.69,"derivative":{"exercise_price":10,"exercise_date":"2016-03-30","expiration_date":"2021-03-30","underlying":"Common Stock","underlying_shares":34158.69},"source":{"system":"sec-edgar","filing":"0001553350-17-001403","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001403/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4128980,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-19T00:37:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":68317.43,"ownership":{"direct":false,"nature":"By Allied"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."},{"field":"security","element":"securityTitle","label":"F3","text":"Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including Allied) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which Allied will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which Allied will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including Allied) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which Allied will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which Allied will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including Allied) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which Allied will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which Allied will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":68317.43,"derivative":{"exercise_price":9,"exercise_date":"2015-10-14","expiration_date":"2020-10-14","underlying":"Common Stock","underlying_shares":68317.43},"source":{"system":"sec-edgar","filing":"0001553350-17-001403","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001403/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4128979,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-12-19T00:37:37.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":1664054,"ownership":{"direct":false,"nature":"By Allied Physicians of California, A Professional Medical Corporation (\"Allied\")"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). Immediately prior to the closing of the Merger (the \"Closing\"), Allied was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Allied were converted into (i) 1,664,054 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) Allied's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 184,894.80 shares of common stock of the Issuer)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares and warrants are owned directly by Allied Physicians of California, A Professional Medical Corporation (\"Allied\"), of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":1664054,"source":{"system":"sec-edgar","filing":"0001553350-17-001403","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001403/lam4.xml","form_type":"4/A","original_submission_date":"2017-12-12"}},{"id":4135196,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":false,"shares":555555,"price":9,"value":4999995.0,"ownership":{"direct":false,"nature":"By Network Medical Management, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"NMM purchased 555,555 investment units at $9.00 per unit. Each investment unit is comprised of (a) one (1) share of Series B Preferred Stock that may be converted into one (1) share of common stock of the Issuer, and (b) one (1) warrant to purchase one (1) share of common stock of the Issuer at an exercise price of $10.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2016-03-30","expiration_date":"2021-03-30","underlying":"Common Stock","underlying_shares":555555},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135195,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":false,"shares":1111111,"price":9,"value":9999999.0,"ownership":{"direct":false,"nature":"By Network Medical Management, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"NMM purchased 1,111,111 investment units at $9.00 per unit. Each investment unit was comprised of (a) one (1) share of Series A Preferred Stock that may be converted into one (1) share of common stock of the Issuer, and (b) one (1) warrant to purchase one (1) share of common stock of the Issuer at an exercise price of $9.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2015-10-14","expiration_date":"2020-10-14","underlying":"Common Stock","underlying_shares":1111111},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135194,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Series B Preferred Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":false,"shares":555555,"price":9,"value":4999995.0,"ownership":{"direct":false,"nature":"By Network Medical Management, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series B Preferred Stock was convertible into common stock, (a) at the option of the holder thereof at any time after issuance, and (b) mandatorily at any time prior to and including March 31, 2017, if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than any transactions with the holder of the Series B Preferred Stock). The Series B Preferred Stock was convertible into common stock at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions."},{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"NMM purchased 555,555 investment units at $9.00 per unit. Each investment unit is comprised of (a) one (1) share of Series B Preferred Stock that may be converted into one (1) share of common stock of the Issuer, and (b) one (1) warrant to purchase one (1) share of common stock of the Issuer at an exercise price of $10.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series B Preferred Stock was convertible into common stock, (a) at the option of the holder thereof at any time after issuance, and (b) mandatorily at any time prior to and including March 31, 2017, if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than any transactions with the holder of the Series B Preferred Stock). The Series B Preferred Stock was convertible into common stock at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."}],"balance_after":0,"derivative":{"exercise_date":"2016-03-30","underlying":"Common Stock","underlying_shares":555555},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135193,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":false,"shares":1111111,"price":9,"value":9999999.0,"ownership":{"direct":false,"nature":"By Network Medical Management, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A Preferred Stock was convertible into Common Stock, at the option of NMM, at any time after issuance at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions. The Series A Preferred Stock was mandatorily convertible not sooner than the earlier to occur of (i) the later of (x) January 31, 2017 or (y) 60 days after the date on which the Issuer files its quarterly report on Form 10Q for the period ending September 30, 2016; or (ii) the date on which the Issuer received the written, irrevocable decision of NMM not to require a redemption of the Series A Preferred Stock, in the event that the Issuer engages in one or more transactions resulting in gross proceeds of not less than $5,000,000, not including the proceeds of the transaction with NMM."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On March 28, 2016, the Issuer filed an Amended and Restated Certificate of Designation (the \"Amended Certificate of Designation\") which amended a provision of the Certification of Designation dated October 15, 2015 (the \"Original Certificate of Designation\") that created the Issuer's Series A Preferred Stock (the \"Series A Preferred Stock\"), which was sold to NMM on October 15, 2015. The Amended Certificate of Designation changed a triggering event for the mandatory conversion of the Series A Preferred Stock. The Series A Preferred Stock had been mandatorily convertible if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than the transaction pursuant to which the Series A Preferred Stock was issued)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Amended Certificate of Designation now provides that the Series A Preferred Stock is mandatorily convertible if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than any transactions with the holder of the Series A Preferred Stock). Furthermore, the Amended Certificate of Designation provides that the Series A Preferred Stock and the Series B Preferred Stock will participate pro rata and pari passu in distributions upon the liquidation, winding up or dissolution of the company."},{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"NMM purchased 1,111,111 investment units at $9.00 per unit. Each investment unit was comprised of (a) one (1) share of Series A Preferred Stock that may be converted into one (1) share of common stock of the Issuer, and (b) one (1) warrant to purchase one (1) share of common stock of the Issuer at an exercise price of $9.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Preferred Stock was convertible into Common Stock, at the option of NMM, at any time after issuance at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions. The Series A Preferred Stock was mandatorily convertible not sooner than the earlier to occur of (i) the later of (x) January 31, 2017 or (y) 60 days after the date on which the Issuer files its quarterly report on Form 10Q for the period ending September 30, 2016; or (ii) the date on which the Issuer received the written, irrevocable decision of NMM not to require a redemption of the Series A Preferred Stock, in the event that the Issuer engages in one or more transactions resulting in gross proceeds of not less than $5,000,000, not including the proceeds of the transaction with NMM."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 28, 2016, the Issuer filed an Amended and Restated Certificate of Designation (the \"Amended Certificate of Designation\") which amended a provision of the Certification of Designation dated October 15, 2015 (the \"Original Certificate of Designation\") that created the Issuer's Series A Preferred Stock (the \"Series A Preferred Stock\"), which was sold to NMM on October 15, 2015. The Amended Certificate of Designation changed a triggering event for the mandatory conversion of the Series A Preferred Stock. The Series A Preferred Stock had been mandatorily convertible if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than the transaction pursuant to which the Series A Preferred Stock was issued)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Amended Certificate of Designation now provides that the Series A Preferred Stock is mandatorily convertible if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than any transactions with the holder of the Series A Preferred Stock). Furthermore, the Amended Certificate of Designation provides that the Series A Preferred Stock and the Series B Preferred Stock will participate pro rata and pari passu in distributions upon the liquidation, winding up or dissolution of the company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These shares and warrants were previously owned directly by NMM, of which Reporting Person is a director and officer. Pursuant to the Merger, and as of December 8, 2017, the Reporting Person no longer indirectly owns any beneficial interest in the Issuer. The following is a description of the disposition of the derivative securities previously disclosed in Table II as indirectly owned by Reporting Person:\n\n (A) upon Closing, NMM relinquished the value of the 1,111,111 shares of Series A preferred stock and 555,555 shares of Series B preferred stock of the Issuer previously held by NMM; and\n\n (B) immediately prior to Closing NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of 1,666,666 warrants to purchase common stock of the Issuer (comprised of 1,111,111 Series A warrants and 555,555 Series B warrants), which warrants were previously held by NMM."}],"balance_after":0,"derivative":{"exercise_date":"2015-10-14","underlying":"Common Stock","underlying_shares":1111111},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135192,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":48585.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."}],"balance_after":48585.84,"derivative":{"exercise_price":11,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":48585.84},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135191,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":51443.83,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."}],"balance_after":51443.43,"derivative":{"exercise_price":10,"exercise_date":"2017-12-08","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":51443.83},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135190,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":31755.42,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."}],"balance_after":31755.42,"derivative":{"exercise_price":10,"underlying":"Common Stock","underlying_shares":31755.42},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135189,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants to purchase Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":63510.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Immediately prior to the closing of the Merger (the \"Closing\"), NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 63,510.90 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 31,755.42 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share."}],"balance_after":63510.9,"derivative":{"exercise_price":9,"underlying":"Common Stock","underlying_shares":63510.9},"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}},{"id":4135188,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":53297,"kind":"person","name":"Lam Thomas S.","position":1,"cik":"0001664499","reported_name":"Lam Thomas S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-12-13T02:21:54.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":1546026,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. (\"NMM\") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the \"Merger\"). The Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,546,026 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 171,781 shares of common stock of the Issuer)."}],"balance_after":1546026,"source":{"system":"sec-edgar","filing":"0001553350-17-001361","document":"lam4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335017001361/lam4.xml","form_type":"4"}}]}